IGEN Networks (IGEN) POS AM 8 Jul 21 Prospectus update (post-effective amendment) Financial data

Cover

Cover	12 Months Ended
	Dec. 31, 2020
Cover [Abstract]
Entity Registrant Name	IGEN NETWORKS CORP
Entity Central Index Key	0001393540
Document Type	POS AM
Amendment Flag	true
Amendment Description	This Post-Effective Amendment No. 1 (this "Post-Effective Amendment No. 1") to the Registration Statement on Form S-1 (File No. 333-248693) (the "Registration Statement"), as originally declared effective by the Securities and Exchange Commission (the "SEC") on September 23, 2020. This Post-Effective Amendment No. 1 is being filed to include information contained in the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which was filed with the SEC on March 31, 2020, and to update certain other information in the Registration Statement. The Registration Statement initially registered the sale of an aggregate of 160,256,410 shares of our Company's shares of Common Stock, par value $0.001. A total of 34,928,645 shares of Common Stock being offered by our Company have been sold, pursuant to the Equity Line, prior to the filing of this Post-Effective Amendment No. 1 and therefore are not included herein. The information included in this filing amend
Entity Small Business	true
Entity Emerging Growth Company	false
Document Period End Date	Dec. 31, 2020
Entity Filer Category	Non-accelerated Filer

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current Assets
Cash	$ 26,731	$ 0
Accounts and other receivables, net	34,830	18,136
Inventory	20,456	4,334
Prepaid expenses and deposits	0	4,013
Total Current Assets	82,017	26,483
Goodwill	505,508	505,508
Total Assets	587,525	531,991
Current Liabilities
Accounts payable and accrued liabilities	846,736	983,358
Current portion of deferred revenue, net of contract assets	96,792	207,566
Notes payable, current portion	5,943	0
Convertible debentures, current portion, net of discount of $22,645 and $55,708, respectively	14,580	2,698
Derivative liabilities	189,775	92,322
Total Current Liabilities	1,153,826	1,285,944
Notes payable, net of current portion	207,219	0
Convertible debentures, net of current portion, net of discount of $141,536 and $287,689, respectively	55,570	18,423
Deferred revenue, net of contract assets and current portion	42,020	54,899
Total Liabilities	1,458,635	1,359,266
Stockholders' Deficit
Common stock: Authorized - 1,490,000,000 shares with $0.001 par value issued and outstanding - 1,192,192,158 and 74,242,196 shares as of December 31, 2020 and 2019, respectively	1,192,192	74,242
Additional paid-in capital	13,068,978	10,697,216
Accumulated deficit	(15,185,157)	(11,630,660)
Total Stockholders' Deficit	(923,017)	(859,202)
Total Liabilities and Stockholders' Deficit	587,525	531,991
Convertible Preferred Stock Series A [Member]
Stockholders' Deficit
Preferred stock value	51,907	31,927
Series B preferred stock [Member]
Stockholders' Deficit
Preferred stock value	$ 1,000	$ 0

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current Liabilities
Net of unamortized discount	$ 22,645	$ 55,708
Convertible debentures, net of current portion, net of discount	$ 141,536	$ 287,689
Stockholders' Deficit
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,490,000,000	1,490,000,000
Common stock, shares issued	1,192,192,158	74,242,196
Common stock, shares outstanding	1,192,192,158	74,242,196
Preferred stock, shares par value	$ 0.001
Preferred stock, shares authorized	10,000,000
Series B preferred stock [Member]
Stockholders' Deficit
Preferred stock, shares par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	10,000,000
Preferred stock, shares issued	1,000,000	0
Preferred stock, shares outstanding	1,000,000	0
Redeemable convertible preferred stock - Series A [Member]
Stockholders' Deficit
Preferred stock, shares par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,250,000	1,250,000
Preferred stock, shares issued	186,450	160,600
Preferred stock, shares outstanding	186,450	160,600
Preferred stock, liquidation preference shares	$ 190,194	$ 167,515
Preferred stock, liquidation preference shares, net of discount	$ 101,104	$ 121,931

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues:
Sales, services	$ 355,690	$ 698,693
Sales, other	12,317	25,126
Total Revenues	368,007	723,819
Cost of goods sold	271,363	516,057
Gross Profit	96,644	207,762
Expenses:
Selling, general and administrative expenses	448,857	484,271
Payroll and related	190,601	332,102
Management and consulting fees	154,077	197,391
Stock-based director expense	277,543	0
Total Expenses	1,071,078	1,013,764
Loss Before Other Income (Expense)	(974,434)	(806,002)
Other Income (Expense):
Accretion of discounts on convertible debentures	(134,263)	(212,982)
Change in fair value of derivative liabilities	(1,079,355)	572,954
Loss on extinguishment of debt, net	(209,009)	(23,324)
Interest expense	(242,411)	(9,719)
Total Other Income (Expense), net	(1,665,038)	326,929
Net Loss before Provision for Income Taxes	(2,639,472)	(479,073)
Provision for Income Taxes	0	0
Net Loss	(2,639,472)	(479,073)
Increase in value of warrants	(370,726)	0
Accrued and deemed dividend on redeemable convertible preferred stock	(544,329)	(102,087)
Net loss attributable to common stockholders	$ (3,554,527)	$ (581,160)
Basic and Diluted Loss per Common Share	$ 0	$ (0.01)
Weighted Average Number of Common Shares Outstanding	786,228,507	68,619,041

Consolidated Statements of Rede

Consolidated Statements of Redeemable Convertible Preferred stock and Stockholders Deficit - USD ($)	Total	Redeemable Convertible Preferred Stock Series A [Member]	Common Stock	Series B, Preferred Share	Additional Paid-In Capital	Accumulated Deficit
Balance, shares at Dec. 31, 2018			66,714,970
Balance, amount at Dec. 31, 2018	$ (556,539)	$ 0	$ 66,715	$ 0	$ 10,426,245	$ (11,049,499)
Stock-based compensation, shares			150,000
Stock-based compensation, amount	51,211	$ 0	$ 150	$ 0	51,061	0
Common stock issued for cash, shares			4,000,000
Common stock issued for cash, amount	135,000	$ 0	$ 4,000	$ 0	131,000	0
Common stock issued in connection with debenture issuance, shares			100,000
Common stock issued in connection with debenture issuance, amount	5,000	$ 0	$ 100	$ 0	4,900	0
Common stock issued for debenture conversion, including related fees, shares			300,000
Common stock issued for debenture conversion, including related fees, amount	7,165	$ 0	$ 300	$ 0	6,865	0
Series A preferred stock issued for cash, net of costs and discounts, shares		202,600
Series A preferred stock issued for cash, net of costs and discounts, amount	0	$ 23,400	$ 0	$ 0	0	0
Accrued dividends and accretion of conversion feature on Series A preferred stock	(46,620)	46,620	0	0	0	(46,620)
Deemed dividends related to conversion feature of Series A preferred stock	(55,468)	$ 0	$ 0	$ 0	0	(55,468)
Common stock issued for Series A preferred stock conversions, shares		(42,000)	2,977,226
Common stock issued for Series A preferred stock conversions, amount	80,122	$ (38,093)	$ 2,977	$ 0	77,145	0
Net loss	(479,073)	$ 0	$ 0	$ 0	0	(479,073)
Balance, shares at Dec. 31, 2019		160,600	74,242,196
Balance, amount at Dec. 31, 2019	(859,202)	$ 31,927	$ 74,242	$ 0	10,697,216	(11,630,660)
Common stock issued for cash, amount	$ 67,072	0	26,829	0	40,243	0
Common stock issued for debenture conversion, including related fees, shares	931,278,827
Common stock issued for debenture conversion, including related fees, amount	$ 1,894,563	0	659,022	0	1,235,541	0
Net loss	(2,639,472)	$ 0	$ 0	$ 0	0	(2,639,472)
Shares of Series A preferred stock for cash, net of costs and discounts, shares		333,850
Shares of Series A preferred stock for cash, net of costs and discounts, amount	(262,888)	$ 0	$ 0	$ 1,000	276,543	0
Conversion of Series A preferred shares to common stock, shares		(308,000)	272,256,929
Accrued dividends on Series A preferred stock	(79,420)	$ 79,420	$ 0	$ 0	0	(79,420)
Shares of common stock issued for cash, shares			44,803,645
Shares of common stock issued for cash, amount	202,973	$ 0	$ 44,804	$ 0	158,169	0
Shares of common stock issued for conversion of convertible note, including fees, shares			659,021,898
Stock-based compensation	14,906	$ 0	$ 0	$ 0	14,906	0
Cashless exercise of warrants, shares			105,038,690
Cashless exercise of warrants, amount	0	$ 0	$ 2,000	$ 0	12,800	0
Increase in fair value of warrants	0	$ 0	$ 0	$ 0	370,726	(370,726)
Issuance of common stock for conversion of payables, shares			26,828,800
Issuance of common stock for commitment fee on equity line, shares			8,000,000
Issuance of common stock for commitment fee on equity line, amount	0	$ 0	$ 8,000	$ 0	(8,000)	0
Balance, shares at Dec. 31, 2020		186,450	1,192,192,158	1,000,000
Balance, amount at Dec. 31, 2020	$ (923,017)	$ 51,907	$ 1,192,192	$ 1,000	$ 13,068,978	$ (15,185,187)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash Flows from Operating Activities
Net loss	$ (2,639,472)	$ (479,073)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of discounts on convertible debentures and preferred stock	134,263	212,982
Bad debts	0	13,835
Change in fair value of derivative liabilities	1,079,355	(572,954)
Interest charge for derivative liabilities in excess of face amount of debt	164,310	0
Loss on settlement of debt	209,009	23,324
Shares issued for services	0	6,000
Stock-based compensation	292,449	64,712
Changes in operating assets and liabilities:
Accounts and other receivables	(16,694)	(7,418)
Inventory	(16,122)	32,360
Prepaid expenses and deposits	0	4,484
Restricted cash	0	0
Accounts payable and accrued liabilities	42,294	176,142
Deferred revenue, net	(123,653)	(131,967)
Net Cash Used in Operating Activities	(874,261)	(657,573)
Cash Flows from Financing Activities
Proceeds from issuance of preferred stock, net of offering costs	303,070	175,000
Proceeds from notes payable	406,449
Repayment of notes payable	(50,000)	0
Proceeds from convertible debentures, net of offering costs	38,500	290,750
Proceeds from issuance of common stock	202,973	135,000
Net Cash Provided by Financing Activities	900,992	600,750
Change in Cash	26,731	(56,823)
Cash, Beginning of Year	0	56,823
Cash, End of Year	26,731	0
Supplemental Disclosures:
Interest paid	0	0
Income taxes paid	0	0
Conversion of notes payable and accrued interest:
Fair value of common shares issued	1,895,562	0
Derecognition of notes payable and accrued interest	(372,454)	0
Derecognition of unamortized discount	229,322	0
Derecognition of derivative liabilities	(1,448,326)	0
Conversion of preferred stock:
Fair value of common stock issued	648,129	0
Derecognition of preferred stock	(376,325)	92,287
Derecognition of unamortized discount	259,971	0
Derecognition of derivative liabilities	(286,782)	0
Deemed divided	(215,039)	(102,088)
Discount related to issuance of preferred stock	256,526	690,398
Deemed dividends on preferred stock (excluding conversions)	(262,901)	(219,767)
Cashless exercise of warrants	105,038	0
Original issue discount on convertible debt	0	68,250
Increase in value of warrants	370,726	0
Conversion of accrued liabilities with issuance of common stock	67,073	0
Issuance of common shares for commitment fee on equity line	8,000	0
Discount for issuance of convertible debt	184,841	0
Reclassification of security deposit to accounts payable	$ 4,013	$ 0

Organization and Description of

Organization and Description of Business	12 Months Ended
	Dec. 31, 2020
Organization and Description of Business
1. Organization and Description of Business	IGEN Networks Corp. (“IGEN”, the “Company”, “we”, “our”) was incorporated in the State of Nevada on November 14, 2006, under the name of Nurse Solutions Inc. On September 19, 2008, the Company changed its name to Sync2 Entertainment Corporation and traded under the symbol SYTO. On September 15, 2008, the Company became a reporting issuer in British Columbia, Canada. On May 26, 2009, the Company changed its name to IGEN Networks Corp. On March 25, 2015, the Company was listed on the Canadian Securities Exchange (CSE) under the trading symbol IGN and the Company became a reporting Venture Issuer in British Columbia and Ontario, Canada. The Company’s principal business is the development and marketing of software services for the automotive industry. The Company works with wireless carriers, hardware suppliers and software developers to provide direct and secure access to information on the vehicle and the driver’s behavior. The software services are delivered from the AWS Cloud to the consumer and their families over the wireless networks and accessed from any mobile or desktop device. The software services are marketed to automotive dealers, financial institutions, and direct-to-consumer through various commercial and consumer brands. Going Concern The consolidated financial statements as of and for the year ended December 31, 2020 have been prepared assuming that the Company will continue as a going concern. The Company has experienced recurring losses from operations and has negative operating cash flows since inception, has a working capital deficit of $1,071,809 and an accumulated deficit of $15,185,157 as of December 31, 2020, and is dependent on its ability to raise capital from stockholders or other sources to sustain operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Ultimately, the Company plans to achieve profitable operations through the increase in revenue base and successfully growing its operations organically or through acquisitions. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Summary of Significant Accounting Policies
2. Summary of Significant Accounting Policies	Basic of Presentation and Consolidation These consolidated financial statements and related notes include the records of the Company and the Company’s wholly-owned subsidiary, Nimbo Tracking LLC, which is based in the USA. All intercompany transactions and balances have been eliminated. These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), are expressed in U.S. dollars, and, in management’s opinion, have been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below. Use of Estimates The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for doubtful accounts, valuation of inventory, the useful life and recoverability of equipment, impairment of goodwill, valuation of notes payable and convertible debentures, fair value of stock-based compensation and derivative liabilities, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three months or less at the time of acquisition to be cash equivalents. Accounts Receivable Accounts receivable are recognized and carried at the original invoice amount less an allowance for expected uncollectible amounts. Inherent in the assessment of the allowance for doubtful accounts are certain judgments and estimates including, among others, the customer’s willingness or ability to pay, the Company’s compliance with customer invoicing requirements, the effect of general economic conditions and the ongoing relationship with the customer. Accounts with outstanding balances longer than the payment terms are considered past due. We do not charge interest on past due balances. The Company writes off trade receivables when all reasonable collection efforts have been exhausted. Bad debt expense is reflected as a component of general and administrative expenses in the consolidated statements of operations. As of December 31, 2020 and 2019, the allowance for doubtful accounts was approximately $22,000 and $21,000, respectively. Inventory Inventory consists of vehicle tracking and recovery devices and is comprised entirely of finished goods that can be resold. Inventory is stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out (FIFO) basis. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling costs. There was no provision for inventory recorded during the years ended December 31, 2020 and 2019. Equipment Office equipment, computer equipment, and software are recorded at cost. Depreciation is provided annually at rates and methods over their estimated useful lives. Management reviews the estimates of useful lives of the assets every year and adjusts them on prospective basis, if needed. All equipment was fully depreciated as of December 31, 2020 and 2019. For purposes of computing depreciation, the method of depreciating equipment is as follows: Computer equipment 3 years straight-line Office equipment 5 years straight-line Software 3 years straight-line Goodwill Goodwill represents the excess of the acquisition price over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized, but is tested for impairment annually on December 31 of each year or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action of assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group. Goodwill impairment is measured as the amount by which a reporting unit’s carrying value exceeds its fair value. The Company has only one reporting unit. Therefore, all of the Company’s goodwill relates to that reporting unit, and at December 31, 2020 and 2019, the carrying value for that reporting unit is negative. Impairment of Long-lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in the circumstances indicate that the carrying value may not be recoverable. If the total of the estimated undiscounted future cash flows is less than the carrying value of the asset, an impairment loss is recognized for the excess of the carrying value over the fair value of the asset during the year the impairment occurs. Fair Value Measurements and Financial Instruments In accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” the Company is to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. See Note 7 for fair value measurement information related to the Company’s derivative liabilities. The fair values of cash and cash equivalents, accounts and other receivables, restricted cash, and accounts payable and accrued liabilities, approximate their carrying values due to the immediate or short-term maturity of these financial instruments. Foreign currency transactions are primarily undertaken in Canadian dollars. The fair value of cash is determined based on “Level 1” inputs and the fair value of derivative liabilities is determined based on “Level 3” inputs. The recorded values of notes payable, approximate their current fair values because of their nature and respective maturity dates or durations. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility to these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. Financial instruments that potentially subject the Company to concentrations of credit risk consists of cash and accounts receivable. The Company places its cash and cash equivalents in what it believes to be credit-worthy financial institutions. Revenue Recognition and Deferred Revenue We recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, using the five-step model, including (1) identify the contract with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue in accordance with U.S. GAAP. Title and risk of loss generally pass to our customers upon delivery, as we have insurance for lost shipments. In limited circumstances where either title or risk of loss pass upon destination or acceptance or when collection is not reasonably assured, we defer revenue recognition until such events occur. We derive substantially all our revenues from the sale of products and services combined into one performance obligation. Product revenue includes the shipment of product according to the agreement with our customers. Service revenue include vehicle tracking services and customer support (technical support), installations and consulting. A contract usually includes both product and services. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. Performance obligations include, but are not limited to, pass-thru harnesses and vehicle tracking services. Almost all of our revenues are derived from customers located in United States of America in the auto industry. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are typically estimated based on observable transactions when these services are not sold on a standalone basis. At contract inception, an assessment of the goods and services promised in the contracts with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer a good or service (or bundle of goods or services). To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Revenue is recognized when our performance obligation has been met. The Company has insignificant revenues related to product sales. For these revenues, the Company considers control to have transferred upon delivery because the Company has a present right to payment at that time, the Company has transferred use of the asset, and the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. For arrangements under which the Company provides vehicle tracking services, which account for the substantial portion of the Company’s revenues, the Company satisfies its performance obligations as those services are performed whereby the customer simultaneously receives and consumes the benefits of such services under the agreement. Revenues are recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. The Company provides product warranties with varying lengths of time and terms. The product warranties are considered to be assurance-type in nature and do not cover anything beyond ensuring that the product is functioning as intended. Based on the guidance in ASC 606, assurance-type warranties do not represent separate performance obligations. The Company has historically experienced a low rate of product returns under the warranty program. Management assesses the business environment, customers’ financial condition, historical collection experience, accounts receivable aging, and customer disputes to determine whether collectability is reasonably assured. Revenue relating to the sale of service fees on its vehicle tracking and recovery services is recognized over the life of the contact. The service renewal fees are offered in terms ranging from 12 to 36 months and are generally payable upon delivery of the vehicle tracking devices or in full upon renewal. Deferred revenues are recorded net of contract assets when cash payments are received from customers in advance of the Company’s performance. Contract assets represent the costs of (1) commission costs, (2) installation costs, and (3) the underlying hardware to enable the Company to perform on its contracts with customers and are amortized using the same method and term as deferred revenues. As of December 31, 2020 and 2019, deferred revenues, net of contract assets totaled $138,812 and $262,465, respectively, and contract assets totaled $66,022 and $143,088, respectively. Any revenue that has been deferred and is expected to be recognized beyond one year is classified as deferred revenue, net of current portion. During the year ended December 31, 2020, the Company recorded additions to deferred revenues of $152,828 and recognized total revenues of $353,547 through the amortization of deferred revenues. During the year ended December 31, 2020, the Company recognized revenues of $303,406 related to deferred revenues outstanding as of December 31, 2019 as the services were performed. Financing Costs and Debt Discount Financing costs and debt discounts are recorded net of notes payable and convertible debentures in the consolidated balance sheets. Amortization of financing costs and the debt discounts is calculated using the effective interest method over the term of the debt and is recorded as interest expense in the consolidated statements of operations. Income Taxes Deferred income taxes are provided on the asset and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Stock-based Compensation The Company accounts for stock-based payments in accordance with stock-based payment accounting guidance which requires all stock-based payments to be recognized based upon their fair values. The fair value of stock-based awards is estimated at the grant date using the Black-Scholes Option Pricing Model and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. The determination of fair value using the Black-Scholes Option Pricing Model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility, risk-free interest rate, expected dividends and projected employee stock option exercise behaviors. The Company accounts for forfeitures of unvested awards as they occur. Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts (including embedded conversion features) that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. Loss Per Share Basic earnings (loss) per share are computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted earnings per share give effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible debentures, using the if-converted method. In computing diluted earnings (loss) per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted earnings (loss) per share exclude all potentially issuable shares if their effect is anti-dilutive. Because the effect of conversion of the Company’s dilutive securities is anti-dilutive, diluted loss per share is the same as basic loss per share for the periods presented. As of December 31, 2020 and 2019, the Company has 262,930,295 and 68,247,452 potentially dilutive shares outstanding, respectively. Recent Accounting Pronouncement In August 2020, the FASB issued ASU 2020-06, ”Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815 - 40)” The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

Accounts and Other Receivables

Accounts and Other Receivables	12 Months Ended
	Dec. 31, 2020
Accounts and Other Receivables
3. Accounts and Other Receivables	December 31, 2020 December 31, 2019 Trade accounts receivable $ 57,298 $ 39,398 Allowance for doubtful accounts (22,468 ) (21,262 ) $ 34,830 $ 18,136

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2020
Goodwill
4. Goodwill	As of December 31, 2020 and 2019, the Company had goodwill of $505,508 related to the acquisition of Nimbo Tracking, LLC.

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	12 Months Ended
	Dec. 31, 2020
Accounts Payable and Accrued Liabilities
5. Accounts Payable and Accrued Liabilities	December 31, 2020 December 31, 2019 Trade accounts payable $ 686,222 $ 744,716 Accrued liabilities 19,349 44,162 Accrued interest payable 19,064 19,064 Payroll and commissions payable 32,101 85,416 Unrecognized tax position 90,000 90,000 $ 846,736 $ 983,358

Convertible Debentures and Note

Convertible Debentures and Notes Payable	12 Months Ended
	Dec. 31, 2020
Convertible Debentures and Notes Payable
6. Convertible Debentures and Notes Payable	On May 17, 2019, the Company entered into a Convertible Promissory Note (“Promissory Note”) with Crown Bridge Partners, LLC (the “Holder”) for a total principal amount of up to $150,000 with cash proceeds of up to $124,500, resulting in an original issue discount of up to $25,500. The Promissory Note bears interest at 7% per annum (with the understanding that the first 12 months of interest of each tranche will be guaranteed). The maturity date is 18 months from the effective date of each payment. The Conversion Price, as defined in the agreement, is the lesser of (i) the lowest Trading Price (as defined below) during the previous 25 trading day period ending on the latest complete trading day prior to the date of this Promissory Note or (ii) the Variable Conversion Price (as defined below). The Variable Conversion Price means the lowest one Trading Price (as defined below) for the common stock during the 25 Trading Day period ending on the last complete Trading Day prior to the Conversion Date. Trading Price means, for any security as of any date, the lesser of the (i) lowest traded price and (ii) lowest closing bid price. Based on the Company’s examination of the conversion feature and the relative accounting guidance, the Company has determined that the conversion feature should be treated as a derivative liability for accounting purposes. Additionally, if at any time while the Promissory Note is outstanding, the Conversion Price is equal to or lower than $0.025, then an additional $10,000 will be automatically added to the principal balance of each tranche funded under the Note. During the quarter ended June 30, 2019, $10,000 was added to the principal balance for the first tranche. In connection with the Promissory Note, the Company also entered into a Securities Purchase Agreement with the Holder which states that the Company will also issue to the Holder a warrant to purchase an amount of shares of its common stock equal to 50% of the face value of each respective tranche divided by $0.10 (for illustrative purposes, the first tranche face value is equal to $50,000, which resulted in the issuance of a warrant to purchase 250,000 shares of the Company’s common stock). Per the terms of the Common Stock Purchase Warrant agreement, on May 17, 2019, the Company issued a warrant to purchase 250,000 shares of common stock with an Exercise Price of $0.10 subject to adjustment (standard anti-dilution features). The agreement contains a down-round provision that automatically resets the exercise price of the warrant to a new exercise price that is equal to the per share price of common stock subsequently issued (including conversions of debt and preferred stock). Upon the lowing of the exercise price, the number of warrants will be increased such that the total proceeds upon exercise is the same amount (see Note 7). If the Market Price of one shares of common stock is greater than the Exercise Price, the Holder may elect to receive Warrant Shares pursuant to cashless exercise, in lieu of cash exercise, per a defined formula in the agreement. During the quarter ended June 30, 2019, the Company received $40,000 in net cash proceeds, after paying $1,500 of direct funding costs. The related principal amount due for the first tranche (“First Tranche”) was $50,000. For the first tranche, using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be $100,000 and recorded a related derivative liability. Related to the derivative liability, the bonus interest, and the direct financing costs, the Company recorded a full debt discount of $60,000 for the Promissory Note, which is being amortized to interest expense over the term of the Promissory Note using the effective interest method and an additional $50,000 directly to interest expense. On December 9, 2019, the Holder converted a portion of the Promissory Note into shares of common stock. The Holder received 300,000 shares of common stock for the conversion of principal, accrued interest, and fees totaling $7,165. During the quarter ended September 30, 2019, the Company received an aggregate of $213,250 in net cash proceeds, after paying $6,750 of direct funding costs, from three note holders under the same terms as the Promissory Note. The related principal amount due for the convertible debt instruments entered into during the quarter ended September 30, 2019 was $255,000. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion features to be approximately $354,000 and recorded the related derivative liabilities. Related to the derivative liabilities, the bonus interest, and the direct financing costs, the Company recorded full debt discounts totaling approximately $255,000 for the notes which is being amortized to interest expense over the term of the notes using the effective interest method and an additional approximately $106,000 directly to interest expense. As the Conversion Price fell below $0.025 per share, during the quarter ended September 30, 2019, $10,000 was added to the principal balance on one of the notes (per the terms of that note). Related to the notes issued during the quarter ended September 30, 2019, the Company issued warrants to purchase a total of 525,000 shares of common stock with an Exercise Price of $0.10 subject to adjustment (standard anti-dilution features). If the Market Price of one shares of common stock is greater than the Exercise Price, the Holder may elect to receive Warrant Shares pursuant to cashless exercise, in lieu of cash exercise, per a defined formula in the agreement. On October 1, 2019, the Company received $37,500 in net cash proceeds from a note holder under the same terms as the Promissory Note. The related principal amount due for the convertible debt instrument was $44,000. In connection with the note, the Company issued 100,000 shares of common stock, which were valued at the market price on the date of issuance of $0.05 per share. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $29,000 and recorded a related derivative liability. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling $41,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. On June 19, 2020, the Company received $19,250 in net cash proceeds from a note holder under the same terms as the Promissory Note. The related principal amount due for the convertible debt instrument was $25,000 and the note matures on December 19, 2021. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $142,000 and recorded a related derivative liability for that amount and a charge to interest expense of approximately $122,000. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling $25,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. On July 10, 2020, the Company received $19,250 in net cash proceeds from a note holder under the same terms as the Promissory Note. The related principal amount due for the convertible debt instrument was $25,000 and the note matures on January 10, 2022. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $61,000 and recorded a related derivative liability for that amount and a charge to interest expense of approximately $42,000. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling $25,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. On November 2, 2020, the Company received $146,500 in net cash proceeds from a note holder under an Inventory Financing Promissory Note. The related principal amount due for the convertible debt instrument was $168,000. The note bears interest at 12% per annum and matures on May 2, 2022. Principal and accrued interest are convertible into common stock at a variable conversion price, which is 80% of the average two lowest traded prices for common stock during a 10-day trading period prior to conversion. Using the Binomial Lattice Model, the Company computed the estimated fair value of the embedded conversion feature to be approximately $99,000 and recorded a related derivative liability for that amount. The Company also issued 2,000,000 shares of common stock to the note holder as additional compensation. The value of the shares, $14,800. Related to the derivative liability, the shares issued, the bonus interest, and the direct financing costs, the Company recorded a debt discount totaling approximately $135,000 for the note, which is being amortized to interest expense over the term of the note using the effective interest method. During the year ended December 31, 2020, the holders of the convertible notes converted a total of $379,203 of principal, interest and fees for a total of 659,021,898 shares of common stock. Related to these conversions during the year ended December 31, 2020, the Company recorded a reduction of the associated derivative liability for the conversion features of $1,448,326 and a reduction of the debt discount of $229,322 as components of the loss on settlement of debt. During the year ended December 31, 2020, the Company recorded $134,263 of interest expense related to the amortization of the debt discounts. During the three months ended March 31, 2020 the Company borrowed $50,000 from a shareholder under the terms of a note payable bearing interest of 8% per annum. The note was repaid with interest (totaling $922) during the three months ended March 31, 2020. On May 4, 2020, the Company entered into a Paycheck Protection Program (“PPP”) Loan with a principal amount of $59,949 through a financial institution under the PPP administered by the SBA and established as part of the CARES Act. The PPP Loan bears interest at 1.0% per annum and matures on May 4, 2022 with the first six months of interest and principal payments deferred. The amount borrowed under the PPP Loan is guaranteed by the U.S. Small Business Administration (“SBA”) and is eligible for forgiveness in an amount equal to the sum of the eligible costs, including payroll, benefits, rent and utilities, incurred by the Company during the 24-week period beginning on the date the Company received the proceeds. The PPP Loan contains customary events of default, and the occurrence of an event of default may result in a claim for the immediate repayment of all amounts outstanding under the PPP Loan. On July 7, 2020, the Company entered into a secured disaster loan with the SBA with a principal amount of $150,000. The SBA loan bears interest at 3.75% per annum and matures in July 2050. The Company is required to make monthly principal and interest payments of $731 beginning in July 2021. As of December 31, 2020 long-term debt matures as follows: Year Ending Notes Payable Convertible Notes Total 2021 $ 5,943 $ 37,224 $ 43,167 2022 32,940 197,106 230,036 2023 28,951 - 28,951 2024 3,296 - 3,296 2025 3,422 - 3,422 Thereafter 138,620 - 138,620 $ 213,162 $ 234,330 $ 447,492

Derivative Liabilities

Derivative Liabilities	12 Months Ended
	Dec. 31, 2020
Derivative Liabilities
7. Derivative Liabilities	During the years ended December 31, 2020 and 2019, the Company had outstanding convertible debentures with variable exercise prices based on market rates (see Note 6) and convertible series A preferred stock with variable exercise prices based on market rates (see Note 9). The Company records the fair value of the conversion features with variable exercise prices based on future market rates in accordance with ASC 815. The fair value of the derivative liabilities is revalued on each balance sheet date with corresponding gains and losses recorded in the consolidated statements of operations. The Company uses a multi-nominal lattice model to fair value the derivative liabilities. The following inputs and assumptions were used to value the conversion features outstanding during the years ended December 31, 2020 and 2019, assuming no expected dividends: 2020 2019 Expected volatility 271-322 % 219% - 264 % Risk free interest rate 0.3-1.41 % 1.55% - 2.34 % Expected life (in years) 0.5-1.5 0.8 – 1.5 The following table presents the Company’s embedded conversion features of its convertible debt and preferred stock measured at fair value on a recurring basis as of December 31, 2020 and 2019. Level 3 Carrying Value as of December 31, 2020 Level 3 Carrying Value as of December 31, 2019 Derivative liabilities: Embedded conversion feature – convertible debt $ 97,024 $ 87,571 Embedded conversion feature – preferred stock 92,751 4,751 $ 189,775 $ 92,322 The following table provides a reconciliation of the beginning and ending balances for the Company’s derivative liabilities measured at fair value using Level 3 inputs: For The Year Ended December 31, 2020 For The Year Ended December 31, 2019 Embedded Conversion Features – Debt Instruments Balances, as of the beginning of the year $ 87,571 $ - Derivative liabilities recorded upon issuance of debt instruments 301,351 483,331 Extinguishment due to conversion of debt instruments (1,448,326 ) (3,055 ) Net changes in fair value included in net loss 1,156,428 (392,705 ) Ending balance $ 97,024 $ 87,571 Embedded Conversion Features – Preferred Stock Balances, as of the beginning of the year $ 4,751 $ - Derivative liabilities recorded upon issuance of preferred stock 519,427 207,067 Extinguishment due to conversion of preferred stock (340,234 ) (22,067 ) Net changes in fair value included in net loss (91,193 ) (180,249 ) Ending balance $ 92,751 $ 4,751 Total ending balance $ 189,775 $ 92,322

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2020
Related Party Transactions
8. Related Party Transactions	(a) During the years ended December 31, 2020 and 2019, the Company incurred approximately $142,000 and $143,000, respectively, in management and consulting fees with an officer and an entity controlled by him. As of December 31, 2020 and 2019, the Company owed approximately $9,000 and $145,000, respectively, to directors and officers and a company controlled by a director, which is included in accounts payable and accrued liabilities. The amounts owed are unsecured, non-interest bearing, and due on demand. (b) During the years ended December 31, 2020 and 2019, the Company incurred approximately $64,000 and $120,000, respectively, in purchases of hardware from a vendor controlled by a director of the Company. As of December 31, 2020 and 2019, the amounts owed to this related-party vendor were approximately $12,000 and $45,000 respectively. (c) During the year ended December 31, 2020, the Company issued 26,828,800 shares of common stock for the conversion of $67,073 of accrued expenses owed to the CEO and VP of Operations.

Redeemable Preferred Stock and

Redeemable Preferred Stock and Stockholders Deficit	12 Months Ended
	Dec. 31, 2020
Redeemable Preferred Stock and Stockholders Deficit
9. Redeemable Preferred Stock and Stockholders' Deficit	Preferred Stock The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.001 per share. The Company has designated 1,250,000 of these shares as Series A Convertible Preferred Stock (“Series A Preferred Stock”). On April 9, 2019 and separately on June 11, 2019, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor and issued 86,000 shares for net proceeds of $75,000 (after deducting $3,000 of direct legal costs) and on June 11, 2019, the Company issued 58,300 shares for net proceeds of $50,000 (after $3,000 deduction of direct legal costs). On September 17, 2019, the Company entered into a Series A Preferred Stock Purchase Agreement with an investor. The Company issued 58,300 shares of net proceeds of $50,000 (after $3,000 deduction of direct legal costs). During the year ended December 31, 2020, the Company entered into a Series A Preferred Stock Purchase Agreements with investors. The Company issued 333,850 shares for proceeds of $303,070. Rights and Privileges of the Series A Preferred Stock · Voting · Dividends · Liquidation Preference · Redemption · Mandatory Redemption · Conversion · Default Adjustments Based on the terms of the conversion feature, the Company could be required to issue an infinite number of shares of common stock. As such, the Company has determined the conversion feature to be a derivative liability under relevant accounting guidance. The Company estimated the fair value of the conversion feature using the Binomial Lattice Model on the date of issuance, on the date of each conversion notice, and remeasures the fair value at each reporting period. During the year ended December 31, 2020, the Company issued 333,850 shares of series A preferred stock for proceeds of $303,070. Related to these issuances, the Company recorded derivative liabilities of $519,427 and discounts to the preferred stock of $256,526, which is being amortized to deemed dividends over the redemption period. Also related to these issuances the Company recorded deemed dividends of approximately $203,000. During 2019, holders converted 42,000 shares of Series A Preferred stock into 2,977,226 shares of common stock at the Variable Conversion Price as defined above, resulting in a loss on extinguishment of $23,000. During the year ended December 31, 2020, the holder of the series A preferred stock converted 308,000 shares of series A preferred stock and accrued dividends into 272,256,929 shares of common stock. Related to these conversions during the year ended December 31, 2020, the Company recorded a reduction of the associated derivative liability for the conversion features of $340,234 and a reduction of the preferred stock discount of $253,896 and $202,021 of deemed dividend. Rights and Privileges of the Series B Preferred Stock On February 10, 2020, the Company designated and subsequently issued 1,000,000 shares of its newly formed Series B Super Voting Preferred Stock. Each share of Series B preferred stock has voting rights equal to 500 shares of common stock, is not entitled to receive dividends, is not convertible into shares of common stock. If the holder of the Series B preferred stock ceases to be a Board Member, the Company will repurchase any Series B preferred stock from the holder for a price of $0.001 per share. If the holder of the Series B preferred stock proposes to transfer any shares of Series B preferred stock, the Company will have 90 days to repurchase the shares for a price of $0.001 per share. The grant date fair value of the Series B preferred stock issued during the three months ended March 31, 2020 was estimated based upon the control premium of the Company, less a 10% discount. $277,543 was recorded to stock-based director compensation expense in the accompanying condensed consolidated statement of operations. Common Stock 2020 During the year ended December 31, 2020, the Company sold a total of 44,803,645 shares of common stock for proceeds of $202,973 of which $51,723 was raised under the Equity Purchase Agreement (see below). During the year ended December 31, 2020 the Company issued a total of 931,278,827 shares of common stock for the conversion of debt, accrued interest and fees, and the conversion of series A preferred stock and accrued dividends. During the year ended December 31, 2020, the Company issued 105,038,690 shares of common stock for the cashless exercise of warrants. During the year ended December 31, 2020, the Company issued 26,828,800 shares of common stock for the conversion of $67,072 of accrued expenses owed to the CEO and VP of Operations. On July 27, 2020, the Company entered into an Equity Purchase Agreement with an investor. Per the terms of the agreement, the investor will purchase up to $2,500,000 of the Company’s common stock at a 20% discount to the market price or the valuation price (as defined). The Company has the right, but not the obligation, to direct the investor to purchase put shares of not less than $5,000 and not more than $175,000 or 200% of the average daily trading value (as defined). During the year ended December 31, 2020, the Company issued 8,000,000 shares of common stock as a commitment fee on an equity line of credit with an investor, which was recorded as an offset to additional paid in capital in the accompanying condensed consolidated financial statements. Also during the year ended December 31, 2020, the Company issued 18,053,645 shares of common stock for $51,723 under the Equity Purchase Agreement. 2019 During the year ended December 31, 2019, the Company sold 4,000,000 shares of common stock for proceeds of $135,000. During the year ended December 31, 2019, the Company issued 150,000 shares of common stock for services valued at $6,000. During the year ended December 31, 2019, the Company issued 100,000 shares of common stock in connection with the issuance of a convertible debenture valued at $5,000 (see Note 7). During the year ended December 31, 2019, the Company issued 300,000 shares of common stock in connection with the conversion of principal under a convertible debenture, along with related fees, valued at $7,165 (see Note 7). During the year ended December 31, 2019, the Company issued 2,977,226 shares of common stock in connection with conversions of Series A Preferred Stock valued at $80,122 (see Note above).

Share Purchase Warrants

Share Purchase Warrants	12 Months Ended
	Dec. 31, 2020
Share Purchase Warrants
10. Share Purchase Warrants	The following table summarizes the activity of the Company’s share purchase warrants: Number of warrants Weighted average exercise price Balance, January 1, 2019 3,899,673 $ 0.20 Issued 775,000 0.10 Expired (147,059 ) 0.35 Balance, December 31, 2019 4,527,614 0.18 Issued - - Adjusted for triggered down-round provisions 315,521,528 0.00 Exercised (96,957,101 ) 0.00 Expired (56,574,123 ) 0.00 Balance, December 31, 2020 166,517,918 $ 0.00 As of December 31, 2020, the following share purchase warrants were outstanding: Number of warrants outstanding Exercise price Expiration date 2,222,222 $ 0.03 December 2, 2024 163,265,304 $ 0.00 September 23, 2024 980,392 $ 0.15 December 2, 2021 50,000 $ 0.20 January 2, 2022 166,517,918 During the year ended December 31, 2020, the Company recognized the triggering of the down-round provisions of certain warrants associated with the convertible debt instruments issued in 2019. As a result, the reset exercise price increased the number of warrant shares accordingly. As of December 31, 2020, the new exercise price for the warrants is $0.000245 per share. Per the relevant accounting guidance, the Company valued the warrants before and after each triggering event and recorded the total increase in value as a deemed dividend to the warrant holder with an offset to additional paid in capital. For the year ended December 31, 2020, the increase in value of the warrants due to the triggering events totaled $370,726 and was properly included in the Company’s earnings per share amounts on the accompanying statement of operations. On August 21, 2020, the Company modified 2,222,222 warrants held by two investors. Per the terms of the modifications, the Company reduced the exercise price from $0.23 to $0.03 and extended the term of the warrants to now expire on December 2, 2024. In accordance with relevant accounting guidance, the Company valued the warrants before and after modification. There was no change in valuation due to the modifications.

Stock Options

Stock Options	12 Months Ended
	Dec. 31, 2020
Stock Options
11. Stock Options	The Company established a stock option plan for directors, officers, employees and consultants of the Company (the “Plan”). The purpose of the Plan is to give to directors, officers, employees and consultants of the Company, as additional compensation, the opportunity to participate in the profitability of the Company by granting to such individuals options, exercisable over periods of up to ten (10) years as determined by the board of directors of the Company, to buy shares of the Company at a price equal to the Market Price (as defined) prevailing on the date the option is granted. As of December 31, 2020, there were 4,765,000 shares available under the Plan. The following table summarizes the activity of the Company’s stock options: Number of options Weighted average exercise price Aggregate intrinsic value Balance, January 1, 2019 4,190,000 $ 0.16 Granted 1,500,000 0.04 Exercised - - Cancelled / forfeited - - Balance, December 31, 2019 5,690,000 $ 0.13 $ - Granted - - Cancelled / forfeited (2,440,000 ) 0.19 Balance, December 31, 2020 3,250,000 $ 0.09 $ - Vested as of December 31, 2020 3,250,000 $ 0.09 $ - Unvested as of December 31, 2020 - $ - $ - Outstanding Exercisable Range of exercise prices Number of shares Weighted average remaining contractual life (years) Weighted average exercise price Number of shares Weighted average exercise price $ 0.04 1,500,000 3.4 0.04 1,500,000 0.04 $ 0.08 250,000 1.8 0.08 250,000 0.08 $ 0.13 1,425,000 1.4 0.13 1,425,000 0.13 $ 0.16 75,000 0.7 0.16 75,000 0.16 3,250,000 2.3 $ 0.09 3,250,000 $ 0.09 During the year ended December 31, 2020, the Company did not issue any options to employees. During the year ended December 31, 2019, the Company issued 1,500,000 options to employees with an estimated fair value per share of $0.04 using the Black-Scholes Option Pricing Model with the following inputs, volatility of 243%, risk-free rate of 2.2%, and an expected term of 5 years. The options vested 25% quarterly over 1 year. During the year ended December 31, 2020 and 2019, the Company recorded $15,000 and $51,000, respectively, of stock-based compensation expense related to stock option grants. As of December 31, 2020, the Company had no unrecognized compensation expense.

Segments

Segments	12 Months Ended
	Dec. 31, 2020
12. Segments	The Company has one reportable segment: vehicle tracking and recovery solutions. The Company allocates resources to and assesses the performance of each reportable segment using information about its revenue and operating income (loss). The Company does not evaluate operating segments using discrete asset information. Segmentation by geographical location is not presented as all revenues are earned in the U.S. Total assets by segment are not presented as that information is not used to allocate resources or assess performance at the segment level and is not reviewed by the Chief Operating Decision Maker of the Company.

Risk and Uncertainities

Risk and Uncertainities	12 Months Ended
	Dec. 31, 2020
Risk and Uncertainities
13. Risks and Uncertainties	The Company extends credit to customers on an unsecured basis in the normal course of business. The Company’s policy is to perform an analysis of the recoverability of its receivables at the end of each reporting period and to establish allowances where appropriate. The Company analyzes historical bad debts and contract losses, customer concentrations, and customer credit-worthiness when evaluating the adequacy of the allowances. During the year ended December 31, 2020 and 2019, the Company had two and one customers which accounted for 61% and 24%, respectively, of total invoiced amounts, which are recorded as deferred revenues and amortized over the related service period to revenues. As of December 31, 2020 and 2019, the Company had three and four customers, respectively, which accounted for 99% and 99%, respectively, of the gross accounts receivable balance. On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency in response to a new strain of a coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve as of the date of this report. Management is actively monitoring the global situation and its effects on the Company’s industry, financial condition, liquidity, and operations. Through December 31, 2020, COVID-19 has had an impact on the economy, the auto industry, and the Company’s 2020 revenue activity. Looking forward, it could continue to have a material adverse effect on the Company’s business, financial condition, liquidity, results of operations, and cash flows.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Taxes
14. Income Taxes	The Company’s income tax provision consists of the following: 2020 2019 Current: Federal $ - $ - State - - Foreign - - Total Current - - Deferred: Federal - - State - - Foreign - - Total Deferred - - Provision for income taxes $ - $ - A reconciliation of income taxes computed by applying the statutory U.S. income tax rate to the Company’s loss before income taxes to the income tax provision is as follows: 2020 2019 Computed tax benefit at federal statutory rate $ (554,289 ) $ (100,605 ) Permanent items 1,778 11,913 Stock-based compensation 58,284 1,050 Incentive stock options - - Conversion feature derivative liability 24,394 (37,852 ) Interest expense, derivative liability 34,505 36,428 Uncertain tax positions - - Impact of difference related to foreign earnings - 1,469 Gain on extinguishment of debt - - Change in fair value of derivative liability 223,699 (42,748 ) Valuation allowance 211,629 130,345 Provision for income taxes $ - $ - Deferred tax assets and liabilities reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are as follows: 2020 2019 Deferred Tax Assets: Net operating loss carryforwards $ 2,501,000 $ 2,192,000 Stock-based compensation 6,000 7,000 Accounts receivable and other timing differences 140,000 197,000 Basis difference in assets and debt (64,000 ) (109,000 ) Total Deferred Tax Asset 2,583,000 2,287,000 Valuation allowance (2,583,000 ) (2,287,000 ) Net Deferred Tax Asset $ - $ - Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets for the U.S. federal and state have been fully offset by a valuation allowance. As of December 31, 2020, the Company had net operating loss carryforwards for federal and state income tax purposes of $ 8,335,000 and $ 8,084,000, respectively, which expire beginning in the year 2029. The Company is required to file US federal and California tax returns, however the Company has not filed its federal or state returns since 2009 Due to the Company’s loss position the statute remains open for any losses carried over into the current year which means all years from 2007 remain open to examination. The Company has adopted FASB ASC 740, “Income Taxes” to account for income taxes. ASC 740 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statement. This standard prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in the tax return. ASC 740 also provides guidance on derecognition of tax benefits, classification on the balance sheet, interest and penalties, accounting in interim periods, disclosure and transaction. In accordance with ASC 740-10-50, the Company is classifying interest and penalties as a component of tax expense. The Company has a reserve related to unrecognized tax positions of $90,000 as of December 31, 2020, which is presented as part of accounts payable and accrued liabilities. These unrecognized tax positions, if recognized, would affect the effective tax rate. A reconciliation of the change in the unrecognized tax positions for the year ended December 31, 2020 is as follows: Federal and State Balance at January 1, 2020 $ 90,000 Additions for tax positions related to current year - Additions for tax positions related to prior years - Balance at December 31, 2020 $ 90,000

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies
15. Commitments and Contingencies	Withheld Payroll Taxes Since its inception, the Company has made several payments to employees for wages, net of state and federal income taxes. Due to cash constraints, the Company has not yet remitted all of these withheld amounts to the appropriate government agency. Accordingly, as of December 31, 2020 and 2019 the Company has recorded $37,984 and $37,984, respectively, related to this obligation in accounts payable and accrued liabilities, including estimated penalties and interest. Operating Lease Rent expense for the years ended December 31, 2020 and 2019 was approximately $16,000 and $39,000, respectively. As our lease is considered short-term under the accounting guidance of ASC 842 as of December 31, 2020, we have not included the related disclosures required under ASC 842. Our lease is a twelve-month lease that expires in May 2021 and upon expiration our lease continues on a month-to-month basis. Our monthly lease expense for this arrangement is approximately $1,000 per month. Indemnities and Guarantees We have made certain indemnities and guarantees, under which we may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions. We indemnify our officers and directors to the maximum extent permitted under the laws of the State of Nevada. The duration of these indemnities and guarantees varies and, in certain cases, is indefinite. These indemnities and guarantees do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities and guarantees in the accompanying consolidated balance sheets. Legal Matters In the ordinary course of business, we may face various claims brought by third parties and may, from time to time, make claims or take legal actions to assert our rights, including intellectual property disputes, contractual disputes and other commercial disputes. Any of these claims could subject us to litigation. Management believes there are currently no claims that are likely to have a material effect on our consolidated financial position and results of operations. The Company has filed a lawsuit against a former distributor for breach of contract resulting in losses to the Company estimated to be in excess of $1,000,000. A court date has been set for June 18, 2021.

Restatements

Restatements	12 Months Ended
	Dec. 31, 2020
Restatements
16. Restatements	During 2020, we discovered that an accounting error had been made related to the Company not properly classifying certain cost of revenue expenses, which were incorrectly included in selling, general, and administrative expenses. It was determined that the error was not material to the 2019 consolidated financial statements. As such, we computed the appropriate amounts related to 2019 and recorded such in the accompanying consolidated financial statements. See below for a summary of the corrections made for this error: Account Previously Recorded Balance Corrected Balance Correction Made Statement of Operations Cost of revenues $ 428,031 $ 516,057 $ 88,026 Selling, general and administrative expenses $ 572,297 $ 484,271 $ (88,026 ) Net loss $ (479,073 ) $ (479,073 ) $ - Loss per share $ (0.01 ) $ (0.01 ) $ -

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events
17. Subsequent Events	The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the consolidated financial statements were available for issuance are disclosed as subsequent events, while the consolidated financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any subsequent events that require adjustment or disclosure in the consolidated financial statements. On January 5, 2021, stockholders holding 1,500,000 shares of $0.001 par value Series B Super Voting Preferred Stock (“Series B Preferred Stock”), consented to amend the Articles of Incorporation. Each share of Series B Preferred Stock has voting power equal to 500 shares of Common Stock. The voted Preferred shares, which equal approximately 62%, of the total voting power of the Company’s issued and outstanding capital stock, consented in writing to amend the Company’s Articles of Incorporation (the “Articles of Amendment”). This consent was sufficient to approve the Articles of Amendment under Nevada law and our Articles of Incorporation, which will increase the Company’s authorized shares of capital stock to 1,750,000,000 shares from 1,500,000,000 shares, of which 1,740,000,000 will be Common Stock, and 10,000,000 will be Preferred Stock, with such rights and preferences as set by the Board of Directors from time to time. On January 5, 2021, the Company converted $16,543 of accrued commissions to the VP of Operations in exchange for 3,243,785 shares of common stock. On January 5, 2021, the Company issued 4,901,961 shares of common stock through a private placement with an investor for cash proceeds of $25,000. On January 14, 2021, the Company issued a total of 7,500,000 shares of common stock to Crown Bridge Partners LLC in accordance with the Equity-Line Purchase Agreement of July 27, 2020 for cash proceeds of $36,000. On February 1, 2021 the Company issued 58,850 Series A Preferred shares to Geneva Roth Remarks Holdings Inc., for cash proceeds of $53,500. On February 11, 2021, the Company issued 500,000 shares of Series B Super Voting Preferred stock to its directors. On February 12, 2021, the Company issued 8,787,246 shares of common stock to Geneva Roth Remarks Holdings, Inc. for the conversion of 58,300 shares of Series A preferred stock. On March 1, 2021 the Company issued 80,850 Series A Preferred shares to Geneva Roth Remarks Holdings Inc. for cash proceeds of $73,500. On March 8, 2021, the Company issued 3,956,522 shares of common stock to Geneva Roth Remarks Holdings, Inc. for the conversion of 35,000 shares of Series A preferred stock. On March 9, 2021, the Company issued 1,437,303 shares of common stock to Geneva Roth Remarks Holdings, Inc. for the conversion of 12,703 shares of Series A preferred stock. On March 26, 2021, the Company issued a total of 9,375,000 shares of common stock to Crown Bridge Partners LLC in accordance with the Equity-Line Purchase Agreement of July 27, 2020 for cash proceeds of $75,000.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Summary of Significant Accounting Policies
Basic of Presentation and Consolidation	These consolidated financial statements and related notes include the records of the Company and the Company’s wholly-owned subsidiary, Nimbo Tracking LLC, which is based in the USA. All intercompany transactions and balances have been eliminated. These consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), are expressed in U.S. dollars, and, in management’s opinion, have been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below.
Use of Estimates	The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for doubtful accounts, valuation of inventory, the useful life and recoverability of equipment, impairment of goodwill, valuation of notes payable and convertible debentures, fair value of stock-based compensation and derivative liabilities, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Cash and Cash Equivalents	The Company considers all highly liquid instruments purchased with an original maturity of three months or less at the time of acquisition to be cash equivalents.
Accounts Receivable	Accounts receivable are recognized and carried at the original invoice amount less an allowance for expected uncollectible amounts. Inherent in the assessment of the allowance for doubtful accounts are certain judgments and estimates including, among others, the customer’s willingness or ability to pay, the Company’s compliance with customer invoicing requirements, the effect of general economic conditions and the ongoing relationship with the customer. Accounts with outstanding balances longer than the payment terms are considered past due. We do not charge interest on past due balances. The Company writes off trade receivables when all reasonable collection efforts have been exhausted. Bad debt expense is reflected as a component of general and administrative expenses in the consolidated statements of operations. As of December 31, 2020 and 2019, the allowance for doubtful accounts was approximately $22,000 and $21,000, respectively.
Inventory	Inventory consists of vehicle tracking and recovery devices and is comprised entirely of finished goods that can be resold. Inventory is stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out (FIFO) basis. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling costs. There was no provision for inventory recorded during the years ended December 31, 2020 and 2019.
Equipment	Office equipment, computer equipment, and software are recorded at cost. Depreciation is provided annually at rates and methods over their estimated useful lives. Management reviews the estimates of useful lives of the assets every year and adjusts them on prospective basis, if needed. All equipment was fully depreciated as of December 31, 2020 and 2019. For purposes of computing depreciation, the method of depreciating equipment is as follows: Computer equipment 3 years straight-line Office equipment 5 years straight-line Software 3 years straight-line
Goodwill	Goodwill represents the excess of the acquisition price over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized, but is tested for impairment annually on December 31 of each year or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action of assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group. Goodwill impairment is measured as the amount by which a reporting unit’s carrying value exceeds its fair value. The Company has only one reporting unit. Therefore, all of the Company’s goodwill relates to that reporting unit, and at December 31, 2020 and 2019, the carrying value for that reporting unit is negative.
Impairment of Long-lived Assets	The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in the circumstances indicate that the carrying value may not be recoverable. If the total of the estimated undiscounted future cash flows is less than the carrying value of the asset, an impairment loss is recognized for the excess of the carrying value over the fair value of the asset during the year the impairment occurs.
Fair Value Measurements and Financial Instruments	In accordance with Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures,” the Company is to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. See Note 7 for fair value measurement information related to the Company’s derivative liabilities. The fair values of cash and cash equivalents, accounts and other receivables, restricted cash, and accounts payable and accrued liabilities, approximate their carrying values due to the immediate or short-term maturity of these financial instruments. Foreign currency transactions are primarily undertaken in Canadian dollars. The fair value of cash is determined based on “Level 1” inputs and the fair value of derivative liabilities is determined based on “Level 3” inputs. The recorded values of notes payable, approximate their current fair values because of their nature and respective maturity dates or durations. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility to these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. Financial instruments that potentially subject the Company to concentrations of credit risk consists of cash and accounts receivable. The Company places its cash and cash equivalents in what it believes to be credit-worthy financial institutions.
Revenue Recognition and Deferred Revenue	We recognize revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, using the five-step model, including (1) identify the contract with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue in accordance with U.S. GAAP. Title and risk of loss generally pass to our customers upon delivery, as we have insurance for lost shipments. In limited circumstances where either title or risk of loss pass upon destination or acceptance or when collection is not reasonably assured, we defer revenue recognition until such events occur. We derive substantially all our revenues from the sale of products and services combined into one performance obligation. Product revenue includes the shipment of product according to the agreement with our customers. Service revenue include vehicle tracking services and customer support (technical support), installations and consulting. A contract usually includes both product and services. For these contracts, the Company accounts for individual performance obligations separately if they are distinct. Performance obligations include, but are not limited to, pass-thru harnesses and vehicle tracking services. Almost all of our revenues are derived from customers located in United States of America in the auto industry. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are typically estimated based on observable transactions when these services are not sold on a standalone basis. At contract inception, an assessment of the goods and services promised in the contracts with customers is performed and a performance obligation is identified for each distinct promise to transfer to the customer a good or service (or bundle of goods or services). To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Revenue is recognized when our performance obligation has been met. The Company has insignificant revenues related to product sales. For these revenues, the Company considers control to have transferred upon delivery because the Company has a present right to payment at that time, the Company has transferred use of the asset, and the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. For arrangements under which the Company provides vehicle tracking services, which account for the substantial portion of the Company’s revenues, the Company satisfies its performance obligations as those services are performed whereby the customer simultaneously receives and consumes the benefits of such services under the agreement. Revenues are recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. The Company provides product warranties with varying lengths of time and terms. The product warranties are considered to be assurance-type in nature and do not cover anything beyond ensuring that the product is functioning as intended. Based on the guidance in ASC 606, assurance-type warranties do not represent separate performance obligations. The Company has historically experienced a low rate of product returns under the warranty program. Management assesses the business environment, customers’ financial condition, historical collection experience, accounts receivable aging, and customer disputes to determine whether collectability is reasonably assured. Revenue relating to the sale of service fees on its vehicle tracking and recovery services is recognized over the life of the contact. The service renewal fees are offered in terms ranging from 12 to 36 months and are generally payable upon delivery of the vehicle tracking devices or in full upon renewal. Deferred revenues are recorded net of contract assets when cash payments are received from customers in advance of the Company’s performance. Contract assets represent the costs of (1) commission costs, (2) installation costs, and (3) the underlying hardware to enable the Company to perform on its contracts with customers and are amortized using the same method and term as deferred revenues. As of December 31, 2020 and 2019, deferred revenues, net of contract assets totaled $138,812 and $262,465, respectively, and contract assets totaled $66,022 and $143,088, respectively. Any revenue that has been deferred and is expected to be recognized beyond one year is classified as deferred revenue, net of current portion. During the year ended December 31, 2020, the Company recorded additions to deferred revenues of $152,828 and recognized total revenues of $353,547 through the amortization of deferred revenues. During the year ended December 31, 2020, the Company recognized revenues of $303,406 related to deferred revenues outstanding as of December 31, 2019 as the services were performed.
Financing Costs and Debt Discount	Financing costs and debt discounts are recorded net of notes payable and convertible debentures in the consolidated balance sheets. Amortization of financing costs and the debt discounts is calculated using the effective interest method over the term of the debt and is recorded as interest expense in the consolidated statements of operations.
Income Taxes	Deferred income taxes are provided on the asset and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Stock-based Compensation	The Company accounts for stock-based payments in accordance with stock-based payment accounting guidance which requires all stock-based payments to be recognized based upon their fair values. The fair value of stock-based awards is estimated at the grant date using the Black-Scholes Option Pricing Model and the portion that is ultimately expected to vest is recognized as compensation cost over the requisite service period. The determination of fair value using the Black-Scholes Option Pricing Model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables, including expected stock price volatility, risk-free interest rate, expected dividends and projected employee stock option exercise behaviors. The Company accounts for forfeitures of unvested awards as they occur.
Derivative Financial Instruments	The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts (including embedded conversion features) that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
Loss Per Share	Basic earnings (loss) per share are computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted earnings per share give effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible debentures, using the if-converted method. In computing diluted earnings (loss) per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted earnings (loss) per share exclude all potentially issuable shares if their effect is anti-dilutive. Because the effect of conversion of the Company’s dilutive securities is anti-dilutive, diluted loss per share is the same as basic loss per share for the periods presented. As of December 31, 2020 and 2019, the Company has 262,930,295 and 68,247,452 potentially dilutive shares outstanding, respectively.
Recent Accounting Pronouncements	In August 2020, the FASB issued ASU 2020-06, ”Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815 - 40)” The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Summary of Significant Accounting Policies
Summary of computing depreciation, method of depreciating equipment	Computer equipment 3 years straight-line Office equipment 5 years straight-line Software 3 years straight-line

Accounts and Other Receivables

Accounts and Other Receivables (Tables)	12 Months Ended
	Dec. 31, 2020
Accounts and Other Receivables
Schedule of Accounts and Other Receivables	December 31, 2020 December 31, 2019 Trade accounts receivable $ 57,298 $ 39,398 Allowance for doubtful accounts (22,468 ) (21,262 ) $ 34,830 $ 18,136

Accounts Payable and Accrued _2

Accounts Payable and Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2020
Accounts Payable and Accrued Liabilities (Tables)
Schedule of Accounts Payable and Accrued Liabilities	December 31, 2020 December 31, 2019 Trade accounts payable $ 686,222 $ 744,716 Accrued liabilities 19,349 44,162 Accrued interest payable 19,064 19,064 Payroll and commissions payable 32,101 85,416 Unrecognized tax position 90,000 90,000 $ 846,736 $ 983,358

Convertible Debentures and No_2

Convertible Debentures and Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2020
Accounts Payable and Accrued Liabilities (Tables)
Schedule of long-term debt matures	Year Ending Notes Payable Convertible Notes Total 2021 $ 5,943 $ 37,224 $ 43,167 2022 32,940 197,106 230,036 2023 28,951 - 28,951 2024 3,296 - 3,296 2025 3,422 - 3,422 Thereafter 138,620 - 138,620 $ 213,162 $ 234,330 $ 447,492

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	12 Months Ended
	Dec. 31, 2020
Derivative Liabilities (Tables)
Schedule of assumptions used fair value derivative liabilities	2020 2019 Expected volatility 271-322 % 219% - 264 % Risk free interest rate 0.3-1.41 % 1.55% - 2.34 % Expected life (in years) 0.5-1.5 0.8 – 1.5
Schedule of derivative liabilities measured at fair value	For The Year Ended December 31, 2020 For The Year Ended December 31, 2019 Embedded Conversion Features – Debt Instruments Balances, as of the beginning of the year $ 87,571 $ - Derivative liabilities recorded upon issuance of debt instruments 301,351 483,331 Extinguishment due to conversion of debt instruments (1,448,326 ) (3,055 ) Net changes in fair value included in net loss 1,156,428 (392,705 ) Ending balance $ 97,024 $ 87,571 Embedded Conversion Features – Preferred Stock Balances, as of the beginning of the year $ 4,751 $ - Derivative liabilities recorded upon issuance of preferred stock 519,427 207,067 Extinguishment due to conversion of preferred stock (340,234 ) (22,067 ) Net changes in fair value included in net loss (91,193 ) (180,249 ) Ending balance $ 92,751 $ 4,751 Total ending balance $ 189,775 $ 92,322
Summary of fair value of derivative liabilities on a recurring basis	Level 3 Carrying Value as of December 31, 2020 Level 3 Carrying Value as of December 31, 2019 Derivative liabilities: Embedded conversion feature – convertible debt $ 97,024 $ 87,571 Embedded conversion feature – preferred stock 92,751 4,751 $ 189,775 $ 92,322

Share Purchase Warrants (Tables

Share Purchase Warrants (Tables)	12 Months Ended
	Dec. 31, 2020
Share Purchase Warrants
Schedule of share purchase warrants	Number of warrants Weighted average exercise price Balance, January 1, 2019 3,899,673 $ 0.20 Issued 775,000 0.10 Expired (147,059 ) 0.35 Balance, December 31, 2019 4,527,614 0.18 Issued - - Adjusted for triggered down-round provisions 315,521,528 0.00 Exercised (96,957,101 ) 0.00 Expired (56,574,123 ) 0.00 Balance, December 31, 2020 166,517,918 $ 0.00
Schedule of share purchase warrants outstanding	Number of warrants outstanding Exercise price Expiration date 2,222,222 $ 0.03 December 2, 2024 163,265,304 $ 0.00 September 23, 2024 980,392 $ 0.15 December 2, 2021 50,000 $ 0.20 January 2, 2022 166,517,918

Stock Options (Tables)

Stock Options (Tables)	12 Months Ended
	Dec. 31, 2020
Stock Options
Schedule of Stock Options Roll Forward	Number of options Weighted average exercise price Aggregate intrinsic value Balance, January 1, 2019 4,190,000 $ 0.16 Granted 1,500,000 0.04 Exercised - - Cancelled / forfeited - - Balance, December 31, 2019 5,690,000 $ 0.13 $ - Granted - - Cancelled / forfeited (2,440,000 ) 0.19 Balance, December 31, 2020 3,250,000 $ 0.09 $ - Vested as of December 31, 2020 3,250,000 $ 0.09 $ - Unvested as of December 31, 2020 - $ - $ -
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range	Outstanding Exercisable Range of exercise prices Number of shares Weighted average remaining contractual life (years) Weighted average exercise price Number of shares Weighted average exercise price $ 0.04 1,500,000 3.4 0.04 1,500,000 0.04 $ 0.08 250,000 1.8 0.08 250,000 0.08 $ 0.13 1,425,000 1.4 0.13 1,425,000 0.13 $ 0.16 75,000 0.7 0.16 75,000 0.16 3,250,000 2.3 $ 0.09 3,250,000 $ 0.09

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Income Taxes
Schedule of income tax provision	2020 2019 Current: Federal $ - $ - State - - Foreign - - Total Current - - Deferred: Federal - - State - - Foreign - - Total Deferred - - Provision for income taxes $ - $ -
Unrecognized tax benefits	Federal and State Balance at January 1, 2020 $ 90,000 Additions for tax positions related to current year - Additions for tax positions related to prior years - Balance at December 31, 2020 $ 90,000
Schedule of deferred tax assets	2020 2019 Deferred Tax Assets: Net operating loss carryforwards $ 2,501,000 $ 2,192,000 Stock-based compensation 6,000 7,000 Accounts receivable and other timing differences 140,000 197,000 Basis difference in assets and debt (64,000 ) (109,000 ) Total Deferred Tax Asset 2,583,000 2,287,000 Valuation allowance (2,583,000 ) (2,287,000 ) Net Deferred Tax Asset $ - $ -
Schedule of reconciliation of income tax expense	2020 2019 Computed tax benefit at federal statutory rate $ (554,289 ) $ (100,605 ) Permanent items 1,778 11,913 Stock-based compensation 58,284 1,050 Incentive stock options - - Conversion feature derivative liability 24,394 (37,852 ) Interest expense, derivative liability 34,505 36,428 Uncertain tax positions - - Impact of difference related to foreign earnings - 1,469 Gain on extinguishment of debt - - Change in fair value of derivative liability 223,699 (42,748 ) Valuation allowance 211,629 130,345 Provision for income taxes $ - $ -

Restatements (Tables)

Restatements (Tables)	12 Months Ended
	Dec. 31, 2020
Income Taxes
Schedule of Restatements	Account Previously Recorded Balance Corrected Balance Correction Made Statement of Operations Cost of revenues $ 428,031 $ 516,057 $ 88,026 Selling, general and administrative expenses $ 572,297 $ 484,271 $ (88,026 ) Net loss $ (479,073 ) $ (479,073 ) $ - Loss per share $ (0.01 ) $ (0.01 ) $ -

Organization and Description _2

Organization and Description of Business (Details Narrative) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Organization and Description of Business (Details Narrative)
Accumulated deficit	$ (15,185,157)	$ (11,630,660)
Working capital deficit	$ (1,071,809)

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2020
Computer Equipment [Member]
Property, Plant and Equipment, Depreciation Methods	Straight-line
Property, Plant and Equipment, Useful Life	3 years
Office Equipment [Member]
Property, Plant and Equipment, Depreciation Methods	Straight-line
Property, Plant and Equipment, Useful Life	5 years
Software [Member]
Property, Plant and Equipment, Depreciation Methods	Straight-line
Property, Plant and Equipment, Useful Life	3 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Additional deferred revenue	$ 152,828
Potentially dilutive shares outstanding	262,930,295	68,247,452
Revenues recognized	$ 353,547
Deferred revenue	138,812	$ 262,465
Allowance for doubtful accounts	22,000	21,000
Contract asset balance [Member]
Deferred revenue	66,022	$ 143,088
Deferred revenues outstanding [Member]
Revenues recognized	$ 303,406

Accounts and Other Receivable_2

Accounts and Other Receivables (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Accounts and Other Receivables
Trade accounts receivable	$ 57,298	$ 39,398
Allowance for doubtful accounts	(22,468)	(21,262)
Accounts and other receivables	$ 34,830	$ 18,136

Goodwill (Details Narrative)

Goodwill (Details Narrative) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Goodwill
Goodwill	$ 505,508	$ 505,508

Accounts Payable and Accrued _3

Accounts Payable and Accrued Liabilities (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Accounts Payable and Accrued Liabilities
Trade accounts payable	$ 686,222	$ 744,716
Accrued liabilities	19,349	44,162
Accrued interest payable	19,064	19,064
Payroll and commissions payable	32,101	85,416
Unrecognized tax position	90,000	90,000
Accounts payable and accrued liabilities	$ 846,736	$ 983,358

Convertible Debentures and No_3

Convertible Debentures and Notes Payable (Details)	Dec. 31, 2020USD ($)
2021	$ 43,167
2022	230,036
2023	28,951
2024	3,296
2025	3,422
Thereafter	138,620
Total	447,492
Notes Payable [Member]
2021	5,943
2022	32,940
2023	28,951
2024	3,296
2025	3,422
Thereafter	138,620
Total	213,162
Convertible Notes [Member]
2021	37,224
2022	197,106
2023	0
2024	0
2025	0
Thereafter	0
Total	$ 234,330

Convertible Debentures and No_4

Convertible Debentures and Notes Payable (Details Narrative) - USD ($)	Nov. 02, 2020	Jul. 10, 2020	Jul. 07, 2020	May 04, 2020	Oct. 01, 2019	Jun. 19, 2020	Dec. 09, 2019	May 17, 2019	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2020
Proceeds from notes payable												$ 406,449
Repayment of notes payable												50,000	$ 0
Interest expenses												242,411	9,719
Loss on settlement of debt												$ (209,009)	$ (23,324)
Convertible Notes [Member]
Debt conversion, converted instrument, shares issued												659,021,898
Interest expenses												$ 134,263
Debt conversion, converted instrument, principal, accrued interest, and fees												379,203
Changes in derivative liability												1,448,326
Loss on settlement of debt												$ 229,322
Promissory Note One [Member]
Proceeds from notes payable		$ 19,250			$ 37,500
Debt discount					41,000
Notes payable					44,000
Derivative liability, embedded conversion feature					$ 29,000
Debt conversion, converted instrument, shares issued					100,000
Conversion price					$ 0.05
Promissory Note [Member]
Interest rate	12.00%
Proceeds from notes payable	$ 146,500					$ 19,250				$ 213,250
Debt discount	168,000	25,000				25,000				255,000	$ 60,000
Notes payable										255,000
Derivative liability, embedded conversion feature	99,000	61,000				142,000				354,000	100,000
Debt conversion, converted instrument, shares issued							300,000
Payment of funding cost										6,750	1,500
First tranche, principal amount	$ 135,000	25,000				25,000					50,000
Interest expenses		$ 42,000				$ 122,000				106,000	$ 50,000
Debt conversion, converted instrument, principal, accrued interest, and fees							$ 7,165			10,000
Additional to principal balance of note										$ 0
Shareholder [Member]
Interest rate									8.00%
Proceeds from notes payable									$ 50,000
Repayment of notes payable									$ 922
Crown Bridge Partners, LLC [Member] | Convertible Promissory Note [Member]
Interest rate								7.00%
Debt maturity								The maturity date is 18 months from the effective date of each payment.
Proceeds from notes payable								$ 124,500
Debt discount								25,500
Line of credit, maximum borrowing capacity								$ 150,000
Additional proceeding, description								Additionally, if at any time while the Promissory Note is outstanding, the Conversion Price is equal to or lower than $0.025, then an additional $10,000 will be automatically added to the principal balance of each tranche funded under the Note. During the quarter ended June 30, 2019, $10,000 was added to the principal balance for the first tranche.
SBA Loans [Member]
Interest rate			3.75%
Debt maturity			July 2050
Monthly principal and interest payments			$ 731
Proceeds from notes payable			$ 150,000
PPP Loan [Member]
Interest rate				1.00%
Debt maturity				Matures on May 4, 2022
Proceeds from notes payable				$ 59,949
Adjustment [Member]
Exercise price										$ 0.10
Issuance of warrants to purchase common stock										525,000				250,000
Common Stock Purchase Warrant Agreement [Member]
Exercise price								$ 0.10
Issuance of warrants to purchase common stock								250,000

Derivative Liabilities (Details

Derivative Liabilities (Details) - Warrants [Member]	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Minimum [Member]
Expected volatility	271.00%	219.00%
Risk free interest rate	0.30%	1.55%
Expected life (in years)	5 months 30 days	9 months 18 days
Maximum [Member]
Expected volatility	322.00%	264.00%
Risk free interest rate	1.41%	2.34%
Expected life (in years)	1 year 5 months 30 days	1 year 5 months 30 days

Derivative Liabilities (Detai_2

Derivative Liabilities (Details 1) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Derivative liabilities
Embedded conversion feature - convertible debt	$ 97,024	$ 87,571
Embedded conversion feature - preferred stock	92,751	4,751
Derivative liabilities	$ 189,775	$ 92,322

Derivative Liabilities (Detai_3

Derivative Liabilities (Details 2) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Embedded Conversion Features - Debt Instrument
Balances, as of the beginning of the year	$ 87,571	$ 0
Derivative liabilities recorded upon issuance of debt instrument	301,351	483,331
Extinguishment due to conversion of debt instruments	(1,448,326)	(3,055)
Net changes in fair value included in net loss	1,156,428	(392,705)
Ending balance	97,024	87,571
Embedded Conversion Features - Preferred Stock
Balances, as of the beginning of the year	4,751	0
Derivative liabilities recorded upon issuance of preferred stock	519,427	207,067
Extinguishment due to conversion of preferred stock	(340,234)	(22,067)
Net changes in fair value included in net loss	(91,193)	(180,249)
Ending balance	92,751	4,751
Total ending balance	$ 189,775	$ 92,322

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Officer [Member]
Management and consulting fees	$ 142,000	$ 143,000
Director [Member]
Due to Related Parties	9,000	145,000
Vendor [Member]
Due to Related Parties	12,000	45,000
Purchase of hardware	$ 64,000	$ 120,000
CEO and VP [Member]
Debt conversion, converted instrument, shares issued	26,828,800
Debt conversion, converted instrument, accrued interest	$ 67,073

Redeemable Preferred Stock an_2

Redeemable Preferred Stock and Stockholders Deficit (Details Narrative) - USD ($)	Feb. 10, 2020	Jun. 11, 2019	Apr. 09, 2019	Jul. 27, 2020	Sep. 17, 2019	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Common Stock issued upon exercise of warrants							105,038,690
Common stock shares issued upon conversion of preferred stock and accrued dividend							931,278,827
Preferred stock, par value							$ 0.001
Preferred stock shares authorized							10,000,000
Proceeds from issuance of stock							$ 202,973	$ 135,000
Common Stock, Shares Issued During Period, Value							648,129	0
Stock based compensation expense							$ 277,543	$ 0
CEO and VP [Member]
Common Stock, shares issued							26,828,800
Accrued expenses							$ 67,072
Debt conversion, converted instrument, shares issued							26,828,800
Debentures [Member]
Common stock shares issued in connection with convertible debt/equity								100,000
Common stock value issued in connection with convertible debt/equity								$ 5,000
Shares issued upon conversion of debentures								300,000
Debt conversion, debentures converted, principal and related fees								$ 7,165
Series A Preferred Stock [Member]
Preferred stock shares authorized							1,250,000
Common stock shares issued in connection with convertible debt/equity								2,977,226
Common stock value issued in connection with convertible debt/equity								$ 80,122
Common Shares [Member]
Proceeds from issuance of stock							$ 202,973	135,000
Common Stock, Shares Issued During Period, Value							$ 44,803,645	$ 4,000,000
Common stock issued for services								150,000
Common stock issued for services, value								$ 6,000
Series A Convertible Preferred Stock [Member] | Holder [Member]
Common stock shares issued upon conversion of preferred stock and accrued dividend							272,256,929	2,977,226
Preferred stock shares converted							308,000	42,000
Loss on extinguishment								$ 23,000
Changes in derivative liability							$ 340,234
Deemed dividend							202,021
Reduction of debt discount							253,896
Series B Super Voting Preferred Stock [Member]
Preferred stock shares authorized	1,000,000
Voting right	Stock has voting rights equal to 500 shares of common stock
Stock based compensation expense						$ 277,543
Repurchase share price	$ 0.001
Equity Purchase Agreement [Member]
Common Stock, Shares Issued During Period, Value							$ 51,723
Common Stock, Shares Issued During Period, Shares							18,053,645
Common stock issued as a commitment fee							8,000,000
Agreement description				Per the terms of the agreement, the investor will purchase up to $2,500,000 of the Companys common stock at a 20% discount to the market price or the valuation price (as defined). The Company has the right, but not the obligation, to direct the investor to purchase put shares of not less than $5,000 and not more than $175,000 or 200% of the average daily trading value
Rights and Privileges of the Series A Preferred Stock [Member]
Voting right							Stock holders have no voting rights
Dividend, percentage							8.00%
Stock conversion, description							At any time after 6 months following the Issuance Date
Series A Preferred Stock Purchase Agreements [Member] | Investor [Member]
Proceeds from issuance of stock		$ 50,000	$ 75,000		$ 50,000		$ 303,070
Common Stock, Shares Issued During Period, Value		58,300	86,000		58,300		333,850
Deemed dividend							203,000
Reduction of debt discount							256,526
Derivative liabilities							$ 519,427
Legal cost		$ 3,000	$ 3,000		$ 3,000

Share Purchase Warrants (Detail

Share Purchase Warrants (Details) - Warrants [Member] - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Number of warrants, beginning balance	4,527,614	3,899,673
Number of warrants, issued		775,000
Number of warrants, Adjusted for triggered down-round provisions	315,521,528
Number of warrants, exercised	(96,957,101)
Number of warrants, expired	(56,574,123)	(147,059)
Number of warrants, ending balance	166,517,918	4,527,614
Weighted average exercise price, beginning balance	$ 0.18	$ 0.20
Weighted average exercise price, issued	0	0.10
Weighted average exercise price, adjusted for triggered down-round provisions	0
Weighted average exercise price, exercised	0
Weighted average exercise price, expired	0	0.35
Weighted average exercise price, ending balance	$ 0	$ 0.18

Share Purchase Warrants (Deta_2

Share Purchase Warrants (Details 1)	12 Months Ended
	Dec. 31, 2020$ / sharesshares
Number of warrants outstanding	166,517,918
Warrants At 0.03 [Member]
Number of warrants outstanding	2,222,222
Exercise price (in Dollars per share) | $ / shares	$ 0.03
Expiry date	December 2, 2024
Warrants At 0.00 [Member]
Number of warrants outstanding	163,265,304
Exercise price (in Dollars per share) | $ / shares	$ 0
Expiry date	September 23, 2024
Warrants At 0.15 [Member]
Number of warrants outstanding	980,392
Exercise price (in Dollars per share) | $ / shares	$ 0.15
Expiry date	December 2, 2021
Warrants At 0.20 [Member]
Number of warrants outstanding	50,000
Exercise price (in Dollars per share) | $ / shares	$ 0.20
Expiry date	January 2, 2022

Share Purchase Warrants (Deta_3

Share Purchase Warrants (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Aug. 21, 2020	Dec. 31, 2020	Dec. 31, 2019
Share Purchase Warrants
Revised exercise price of warrants	$ 0.03	$ 0.000245
Revised numbers of warrants	2,222,222
Maturity date of warrants	Dec. 2, 2024
Increase in value of warrants due to triggering events		$ 370,726	$ 0

Stock Options (Details)

Stock Options (Details) - Stock Option [Member] - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Number of warrants, beginning balance	5,690,000	4,190,000
Number of shares, issued		1,500,000
Number of shares, exercised
Number of warrants, expired	(2,440,000)
Number of warrants, ending balance	3,250,000	5,690,000
Number of shares, Vested	3,250,000
Number of shares, Unvested
Weighted average exercise price, beginning balance	$ 0.13	$ 0.16
Weighted average exercise price, issued	0	0.04
Weighted average exercise price, exercised		0
Weighted average exercise price Cancelled / forfeited	0.19	0
Weighted average exercise price, ending balance	0.09	$ 0.13
Weighted average exercise price, Vested	0.09
Weighted average exercise price, Unvested	$ 0

Stock Options (Details 1)

Stock Options (Details 1) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Stock Option [Member]
Options Outstanding, Number of shares (in Shares)	3,250,000	5,690,000	4,190,000
Options Outstanding, Weighted average remaining contractual life	2 years 3 months 18 days
Options Outstanding, Weighted average exercise price	$ 0.9
Options Exercisable, Number of shares (in Shares)	3,250,000
Options Exercisable, Weighted average exercise price	$ 0.9
Options 001 [Member]
Range of exercise prices	$ 0.04
Options Outstanding, Number of shares (in Shares)	1,500,000
Options Outstanding, Weighted average remaining contractual life	3 years 4 months 24 days
Options Outstanding, Weighted average exercise price	$ 0.04
Options Exercisable, Number of shares (in Shares)	1,500,000
Options Exercisable, Weighted average exercise price	$ 0.04
Options 002 [Member]
Range of exercise prices	$ 0.08
Options Outstanding, Number of shares (in Shares)	250,000
Options Outstanding, Weighted average remaining contractual life	1 year 9 months 18 days
Options Outstanding, Weighted average exercise price	$ 0.08
Options Exercisable, Number of shares (in Shares)	250,000
Options Exercisable, Weighted average exercise price	$ 0.08
Options 03 [Member]
Range of exercise prices	$ 0.13
Options Outstanding, Number of shares (in Shares)	1,425,000
Options Outstanding, Weighted average remaining contractual life	1 year 4 months 24 days
Options Outstanding, Weighted average exercise price	$ 0.13
Options Exercisable, Number of shares (in Shares)	1,425,000
Options Exercisable, Weighted average exercise price	$ 0.13
Options 04 [Member]
Range of exercise prices	$ 0.16
Options Outstanding, Number of shares (in Shares)	75,000
Options Outstanding, Weighted average remaining contractual life	8 months 12 days
Options Outstanding, Weighted average exercise price	$ 0.16
Options Exercisable, Number of shares (in Shares)	75,000
Options Exercisable, Weighted average exercise price	$ 0.16

Stock Options (Details Narrativ

Stock Options (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Stock-based compensation	$ 15,000	$ 51,000
Stock option plan [Member]
Common stock shares reserved under plan	4,765,000
Stock options maturity period	10 years
Equity Option [Member] | Employee [Member]
Stock options issued to related party		1,500,000
Stock options issued to related party, fair value		$ 0.04
Volatility rate		243.00%
Risk-free interest rate		2.20%
Expected term		5 years
Stock options vesting percentage, periodically		25.00%
Frequency of periodic vesting of stock options		Quarterly
Stock options vesting period		1 year

Risks and Uncertainties (Detail

Risks and Uncertainties (Details Narrative) - Customer Concentration Risk	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Sales Revenue, Net [Member]
Concentration Risk, Percentage	61.00%	24.00%
Accounts Receivable [Member]
Concentration Risk, Percentage	99.00%	99.00%

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Current:
Federal	$ 0	$ 0
State	0	0
Foreign	0	0
Total Current	0	0
Deferred:
Federal	0	0
State	0	0
Foreign	0	0
Total Deferred	0	0
Provision for Income Taxes	$ 0	$ 0

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Gain on extinguishment of debt	$ (209,009)	$ (23,324)
Provision for income taxes	0	0
Reconciliation of income taxes [Member]
Computed tax benefit at federal statutory rate	(554,289)	(100,605)
Permanent items	1,778	11,913
Stock-based compensation	58,284	1,050
Incentive stock options	0	0
Conversion feature derivative liability	24,394	(37,852)
Interest expense, derivative liability	34,505	36,428
Uncertain tax positions	0	0
Impact of difference related to foreign earnings	0	1,469
Gain on extinguishment of debt	0	0
Change in fair value of derivative liability	223,699	(42,748)
Valuation allowance	211,629	130,345
Provision for income taxes	$ 0	$ 0

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Deferred Tax Assets:
Net operating loss carryforwards	$ 2,501,000	$ 2,192,000
Stock-based compensation	6,000	7,000
Accounts receivable and other timing differences	140,000	197,000
Basis difference in assets and debt	(64,000)	(109,000)
Total Deferred Tax Asset	2,583,000	2,287,000
Valuation allowance	(2,583,000)	(2,287,000)
Net Deferred Tax Asset	$ 0	$ 0

Income Taxes (Details 3)

Income Taxes (Details 3) - Federal and State [Member]	12 Months Ended
	Dec. 31, 2020USD ($)
Unrecognized tax benefit, beginning	$ 90,000
Additions for tax positions related to current year	0
Additions for tax positions related to prior years	0
Unrecognized tax benefit, ending	$ 90,000

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Taxes (Details Narrative)
Net operating loss carryforwards, federal	$ 8,335,000
Net operating loss carryforwards, state	$ 8,084,000
Operating loss carry forward, expiry date, description	Expire beginning in the year 2029
Unrecognized tex benefit	$ 90,000	$ 90,000

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Commitments and Contingencies
Obligation in accounts payable and liabilities	$ 37,984	$ 37,984
Rent expenses	16,000	$ 39,000
Monthly lease expenses	1,000
Loss on breach of contract	$ 1,000,000

Restatements (Details)

Restatements (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Statement of Operations
Cost of revenues	$ 271,363	$ 516,057
Selling, general and administrative expenses	448,857	484,271
Net loss	$ (2,639,472)	$ (479,073)
Loss per share	$ 0	$ (0.01)
Previously Recorded Balance [Member]
Statement of Operations
Cost of revenues	$ 428,031
Selling, general and administrative expenses	572,297
Net loss	$ (479,073)
Loss per share	$ (0.01)
Corrected Balance [Member]
Statement of Operations
Cost of revenues	$ 516,057
Selling, general and administrative expenses	484,271
Net loss	$ (479,073)
Loss per share	$ (0.01)
Correction Made [Member]
Statement of Operations
Cost of revenues	$ 88,026
Selling, general and administrative expenses	88,026
Net loss	$ 0
Loss per share	$ 0

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Mar. 09, 2021	Mar. 08, 2021	Feb. 12, 2021	Jan. 14, 2021	Jan. 05, 2021	Feb. 10, 2020	Jul. 27, 2020	Dec. 31, 2020	Dec. 31, 2019	Mar. 26, 2021	Feb. 11, 2021
Common stock, shares issued								1,192,192,158	74,242,196
Common stock, shares authorized								1,490,000,000	1,490,000,000
Preferred stock shares authorized								10,000,000
Preferred stock, shares par value								$ 0.001
Common stock, shares issued to related party, amount								$ 202,973
Common stock shares issued under private placement, amount								648,129	$ 0
VP of operations [Member] | Subsequent Event [Member] | Accrued commission [Member]
Common stock, Conversion of Stock, Shares Issued					16,543
Debt conversion, converted instrument, shares issued					3,243,785
Series A Preferred shares [Member] | Geneva Roth Remarks Holdings Inc. [Member] | Subsequent Event [Member]
Common stock, Conversion of Stock, Shares Issued	1,437,303	3,956,522	8,787,246
Debt conversion, converted instrument, shares issued	12,703	35,000	58,300
Series A Preferred shares [Member] | Geneva Roth Remarks Holdings Inc. [Member] | February 1, 2021 [Member]
Preferred stock, shares issued, amount								53,500
Series A Preferred shares [Member] | Geneva Roth Remarks Holdings Inc. [Member] | March 1, 2021 [Member]
Preferred stock, shares issued, amount								$ 73,500
Debt conversion, converted instrument, shares issued								80,850
Series B Super Voting Preferred Stock [Member]
Preferred stock shares authorized						1,000,000
Voting right						Stock has voting rights equal to 500 shares of common stock
Series B Super Voting Preferred Stock [Member] | Subsequent Event [Member] | Board of Directors [Member]
Common stock, shares authorized					1,740,000,000
Preferred stock, shares issued											500,000
Preferred stock shares authorized					10,000,000
Series B Super Voting Preferred Stock [Member]
Preferred stock, shares issued					1,500,000
Preferred stock, shares par value					$ 0.001
Voting right					Each share of Series B Preferred Stock has voting power equal to 500 shares of Common Stock. The voted Preferred shares, which equal approximately 62%
Crown Bridge Partners LLC [Member] | Equity-Line Purchase Agreement [Member]
Common stock, shares issued										9,375,000
Cash proceeds							$ 75,000
Crown Bridge Partners LLC [Member] | Subsequent Event [Member] | Equity-Line Purchase Agreement [Member]
Common stock, shares issued to related party, shares				7,500,000
Common stock, shares issued to related party, amount				$ 36,000
Investor [Member] | Subsequent Event [Member]
Common stock shares issued under private placement, shares					4,901,961
Common stock shares issued under private placement, amount					$ 25,000